期刊文献+

2型糖尿病颈动脉内中膜厚度与亚甲基四氢叶酸还原酶基因C677T多态性及血浆同型半胱氨酸水平的关系 被引量:2

The relationship of carotid intima-media thickness with C677T polymorphism of MTHFR and plasma homocysteinc level in type 2 diabetes
原文传递
导出
摘要 目的探讨亚甲基四氢叶酸还原酶(MTHFR)基因C677T多态性及同型半胱氨酸水平与早期2型糖尿病(T2DM)颈动脉内中膜厚度(IMT)的关系及影响因素。方法测定T2DM患者及对照组(NC)颈动脉IMT,分为糖尿病无内中膜增厚组(DM1)和糖尿病合并内中膜增厚组(DM2)。用PCR-RFLP检测MTHFR基因C677T多态性。结果 DM2组MTHFR C677T基因TT基因型频率与NC组比较明显增高(40.4% vs 17.3%,P<0.01),与DM1组比较明显增高(40.4% vs 17.9%,P<0.01),DM1组与NC组比较无统计学差异(17.9% vs 17.3%,P>0.05)。T等位基因频率DM2组与NC组比较明显增高(57.0% vs 33.7%,P<0.01),与DM1组比较明显增高(57.0% vs 42.9%,P<0.01),差异有统计学意义。结论高同型半胱氨酸血症、T等位基因是早期糖尿病患者颈动脉内中膜增厚的危险因素之一,血浆同型半胱氨酸水平与MTHFR C677T基因多态性有关。 Objective To investigate the relationship of carotid intima-media thickness with C677T polymorphism of MTHFR and plasma homocysteine level in type 2 diabetes Methods The 226 T2DM cases were divided into two groups according to the IMT: normal (DM1)and thicked IMT (DMz). Plasma concentration of total Hcy was measured by direct chemiluminescence. Genetic C677T polymorphism of MTHFR was examined by polymerase chain reaction restriction fragment length polymorphisms (PCR-RFLP). Carotid IMT was determined by the use of the Doppler ultrasonography. Results The frequency of TT genotype in DM2 was significantly higher than that in NC group (40. 4% vs 17.3%, P=0. 003), the frequency of TT genotype in DM2 group was significantly higher than that in DM1 group (40.4 % vs 17.9 %, P=0.001). Similarly, the frequency of T allele in DM2 group was significantly higher than that in NC and DM1 group (57.0% vs 33.7%vs 42.9%, P〈0.01). Conclusions Hyperhomocysteinemia and T allele seems to be the risk factors of early atherosclerosis in patients with type 2 diabetes. Mutation in MTHFR is associated with elevated plasma levels of Hcy.
作者 张巧慧 柳洁
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2009年第5期356-358,共3页 Chinese Journal of Diabetes
关键词 同型半胱氨酸 亚甲基四氢叶酸还原酶 糖尿病 动脉粥样硬化 Homocysteine Methylenetetrahydrofolate reductase Diabetes mellitus Atherosclerosis
  • 相关文献

参考文献7

  • 1Frosst P,Blom HJ,Milos R,et al.A candidate genetic risk factor for vascular disease:a common mutation in methylenetetrahydrofolate reductase.Nat Genet,1995,10:111-113.
  • 2Lentz SR.Mechanisms of homocysteine-induced atherothrombosis.J Thromb Haemost,2005,3:1646-1654.
  • 3Schneider JA,Rees DC,Liu YT,et al.Worldwide distribution of a common methylenetetrahydrofolate reductase mutation.Am J Hum Genet,1998,62:1258-1260.
  • 4Frost D,Frohlich B,Beischer W.[Subclinical arteriosclerosis in patients with newly diagnosed type 2 diabetes mellitus.Demonstration by high-resolution ultrasound measurements of intima-media thickness of the common carotid and femoral arteries].Dtsch Med Wochenschr,2000,125:648-654.
  • 5Durga J,Verhoef P,Bots ML,et al.Homocysteine and carotid intima-media thickness:a critical appraisal of the evidence.Atherosclerosis,2004,176:1-19.
  • 6Mazza A,Motti C,Nulli A,et al.Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.Metabolism,2000,49:718-723.
  • 7Sun J,Xu Y,Xue J,et al.Methylenetetrahydrofolate reductase polymorphism associated with susceptibility to coronary heart disease in Chinese type 2 diabetic patients.Mol Cell Endocrinol,2005,229:95-101.

同被引文献13

  • 1Sun JZ,Xu YC,Lu HY,et al.Polymorphism of the methylenetetrahydrofolate reductase gene association with homocysteine and ischemic stroke in type 2 diabetes[J].Neurology India,2009,57(5):589-593.
  • 2Anna LS,Ana PF,Jarbas EC,et al.Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus[J].Pathophysiol Haemost Thromb,2008,36(5):275-281.
  • 3Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[ J]. New England Journal of Medicine, 2010, 562 (12): 1090-1101.
  • 4Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vul- nerable patient: a call for new definitions and risk assessment strate- gies: Part I[J]. Circulation, 2003,108(14) :1644 - 1672.
  • 5Hotoleanu C, ChoukyE. Hyperhomocysteinemia and methylenetetra- hydrofolate reductase polymorphism in a patient with coronary artery disease and repetitive miscarriages[ J]. Rom J Intern Med,2012, 50 (4) : 313 -316.
  • 6Moller J, Nielsen GM, Tvedegaard KC, et al. A meta - analysis of cerebrovascular disease and hyperhomocysteinemia [ J ]. Scand J Clin Lab Invest ,2000,60 ( 6 ) :491 - 500.
  • 7Lentz SR. Mechanisms of homocysteine - induced atherothrombosis [ J]. J Thromb Haemost,2005,3 : 1646 - 1654.
  • 8闻杰,陆志强,李晓牧,吴丹,张忆文,滕香宇,谭燕,殳雪怡,杨永年.亚甲基四氢叶酸还原酶基因多态性及同型半胱氨酸与2型糖尿病微量白蛋白尿的相关性[J].上海医学,2008,31(1):47-51. 被引量:4
  • 9华扬,高山,吴钢,潘旭东,钱素云.经颅多普勒超声操作规范及诊断标准指南[J].中华医学超声杂志(电子版),2008,5(2):2-6. 被引量:122
  • 10张阳东,时磊,于敏,翁代慧,刘晨,李晓宁.中国汉族人群亚甲基四氢叶酸还原酶基因多态性与2型糖尿病的相关性研究[J].现代检验医学杂志,2010,25(1):14-16. 被引量:11

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部